Pre-operative Antihypertension Strategies-Carotid Artery Stenting

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 560 participants.

Also called NCT05905848

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 560 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05905848
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05905848. Randomized; single masking; primary purpose prevention. Start 2023-06-15 (anticipated); primary completion 2025-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pre-operative Antihypertension Strategies-Carotid Artery Stenting
Acronym
PASS-CAS
Condition
Carotid Stenosis
Intervention (Drug)
administering RASI (the trade name or universal name will not be stipulated) before stenting
Intervention (Drug)
administering CCB (the trade name or universal name will not be stipulated) before stenting
Lead sponsor
West China Hospital (class: other)

Record details

Record id
cardio:ct-nct05905848
Content hash
32485e95ef027962323817c6fee2894d97fae607da892f0872b852755798e0ec